An expression screen to identify genes important for trastuzumab resistance: Ccl19.
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2026
|
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901557063188480 |
|---|---|
| author | Mamoor, Shahan |
| author_facet | Mamoor, Shahan |
| contents | <p>We measured total transcription by RNA-sequencing in patients sensitive or resistant to treatment with trastuzumab for HER2+ breast cancer for discovery of genes that confer or support resistance to HER2-targeted therapies in humans. In this manuscript we describe identification of Ccl19 as a candidate gene product of the trastuzumab resistance gene expression signature. </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20244914 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | An expression screen to identify genes important for trastuzumab resistance: Ccl19. Mamoor, Shahan <p>We measured total transcription by RNA-sequencing in patients sensitive or resistant to treatment with trastuzumab for HER2+ breast cancer for discovery of genes that confer or support resistance to HER2-targeted therapies in humans. In this manuscript we describe identification of Ccl19 as a candidate gene product of the trastuzumab resistance gene expression signature. </p> |
| title | An expression screen to identify genes important for trastuzumab resistance: Ccl19. |
| url | https://doi.org/10.5281/zenodo.20244914 |